Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe the first post of yours I totally agree with, that is on salary reductions. I would not blame anybody for not buying, or blame for selling on the principle of the idea
that is the worst thing that is beyond doubt, although I don't remember percentage. But even as we discuss, people continue to buy. A bunch of us bought by the way after that was known. It certainly won't stop me from buying, if other indicators wake capt. 370
I don't think so, if Roth is supporting the company they probably did not start until with this offering just completed.
There is of course the VOTE to consider but lastly after a reverse split if they can't get $8 or $9 million minimum out of the next offering, then I will illustrate again that is like a limp spaghetti noodle trying to bench press 500 pounds
exactly, I suppose 2nd biggest reason for voting NO by many is the belief that somebody wants to take over OM small market potential on what pharmaceuticals would believe conservatively might be almost 3 years away
There is a large universe of companies to shop around in for pharms with money. They might casually think chemosat is a good little critter, and then their next phrase at the table "please pass me the potatoes"
YEs, you picked up on it more clearly initially. I am 50/50 on Roth providing surprisingly good support after a steep dip on reverse split. I don't believe athenex has anything to do with this company.
If Roth supports, they would be betting on big uptick soon in enrollment rate, ie they have to like Simpson or why bet such????
I wouldn't try to skim milk off a dead cow, so who knows????
I already mentioned my ancient posting history, so it is possible they mined an ancient IHUB poster who was too bullish clearly in 2010 but when filings say submission is likely after 2019 ... The filing speaks for itself
I decided to vote YES. I understand well the pessimism for reverse split. No matter whether reverse split or not, bankruptcy remains a possibility. I thought in late October/ early November that bankruptcy was imminent.
Might as well because anybody funding $20 m knows all that from filing. Given the ugly news though, I suspect delcath would be pleased to get a bandaid as large as $10 M. The news on 2020 is not really surprising but she is making clear as a bell, not likely rational excitement to work with for at least several months
Assumption:
Reverse split or bankruptcy where shareholders get zero. Reasons too long to the finish line for tiny OM revenue, does not excite ATNX etc.., Pedder enjoys jovial networking and fee for bod
Hard to say on reverse split when it is good to buy if ever. Not today anyway unless a quick merciful spike or insane spec spikes
Give it up Trompete. We must have crash landed here and we read and write as we were taught on Alpha Centauri. Everybody else is posting good news best as I can tell
Possible approval in 2018 suggestion of Rap vs Simpson being conservative translation, we will do pretty good if FDA approval in 2020
As well the financial fiasco has hurt Simpson's plans, she has put out one of the most honest press releases IMO today as one could ever, ever expect
Sorry Rap and all, revenue a disappointment as still about 700K and the biggie NDA submission likely in 2020, then expect at least 4 to 6 months for an approval
Heads of companies could come up with multiple ideas as to why sometimes as general they must lose some troops. The chances are not attractive and cost is not small to get a product to approval. Delcath did not even have a good enough filter to have a chance of long term success until under the so called evil Hobbs in 2012, his team created gen 2. I like to give credit where credit due.
So a bunch of people lost money on a bet that everybody knew by 2012 was based on a phase 3 using the WRONG filter. They got mad a year later in 2013 when FDA made it clear they wanted a re do with gen 2 from scratch
The real complete story is so much more interesting than ethics this and ethics that, and which party is lacking in ethics
I lived those times. I wish I put myself in the category of selling all my shares in 2010 on 2010 info as ... the rest of the story most don't know or care
I have one conspiracy idea, but has nothing to do with your conspiracies or delcath
If that is the way you want to see. Why would a zillion people vote NO without any coherent idea as to how that will profit them? That is a bigger puzzle than the company
I don't think the company is so full of evil plots and conspiracies etc.., but expecting the unexpected is a smart view
The black and white is this is a dilution machine, that for last 1.5 years has been totally out of control, destroying any rational calculation of risk vs. reward. The company may have an idea of the amount of future dilution, but what company in this situation would ever forecast in specifics? I believe only one idea is solid for having a willful desire to destroy a company. Simply "DISLIKE OF COMPANY"
And that is flimsy as a wet noodle, just sell
It is not obvious, but most think it is obvious as to how the dilution will go.
With so many uncertainties, I am glad I sold out. If I was holding, short term target .014 to sell into
Maybe if you listened to the FDA Odac hearing in May 2013, you would have a better perspective on how tough the FDA is. Also I don't think submissions to FDA are a piece of cake as many would wish.
Nobody wants to believe Simpson is sharp clinically apparently, if given time and money we would see. I don't know on vote whether YES or NO, but a YES should give some a reason to think more on these topics
I certainly read the boards and the sentiment in June, the correct historical perspective imo could be found in posts all over the place and does not support your claim for the huge run up
Part 1 is true, vast amount of money needed to get to approvals and for a very small market OM. The argument could be made it is just not a commercially interesting situation for any ship/pharmaceutical
The next 20 million dollars though could be far more dilutive than way further downstream, if the market cap goes much higher after the 20 million is raised. Can't say too often even going into 2011 right before the FDA handed a refusal to file of first submission, market cap surged up again to $500M
It all stems from a bad read on Simpson. For such a small enterprise that was in bad standing in 2013, my opinion Simpson is absolutely the BEST clinically that realistically could be asked for.
The convertible was the best that could be found in 2016 but it completely destroyed belief in the company. I definitely believe if the company landed enough money 90 percent chance of eventual buy out or approval
I would not predict as high as 90 percent if an actual bankruptcy
Theoretically forcing bankruptcy might conceivably be good for mankind. It is most theoretical, since post bankruptcy would be unpredictable like everything always is.
It is most strange though to invest in a company and then to try to force it in bankruptcy.
Negative truths are tough to swallow, but I suggest keep an open mind for down the road. Also with a low market cap, there could be some spikes shortly, crystal balls are in short supply
A YES vote definitely is a signal. That would mean unit holders expected reverse split all along. I will have to consider buying, but still the post offering is likely best gamble
No, I considered a quick flip this week but did nothing. Bears have their very legitimate place here, who knows a bear can become a bull if they so wish
It is even fair to think the worst of Simpson or even good to think if it saves money, wish for the last 4 1/2 years I had thought she was the worst of the worst. I highly, highly doubt that she is the worst though
That explains well one reason there may no buy out potential. The general principle probably of many companies is to get involved only rarely with companies that are a long way from approval.
Near an approval might be a different story as then if they so decide OM revenue could offset partially ICC phase 3 costs and ICC phase 3 has a healthy start ...
IF the best Roth scenario, Roth is supporting the new big boys their preferred clients, obviously this last offering was not healthy for people like me with a cost basis of .039 nor even healthy for the common at .02.
Only time will tell if Roth is actually a significant financial partner. Delcath on the other hand probably can't spin a good phase 3 story before 2nd half of year, but failure by delcath to advance enrollment means failure for all
That is exactly why the vote will be quite interesting, and if RS then an offering will be quite interesting
My theory would be if positives that means Roth plans to work hand in hand with Simpson. Roth has to support the company staunchly to firmly end this nightmare
Simpson has not even given a single hint on phase 3 except enrollment is behind schedule. The original schedule was 240 full enrollment by June of 2018 and end of phase 3 for June of 2019.
No, bod does not make that much. Pedder as an example is probably as greedy as far as we know as any single individual, but if the jig was up he would probably bend
Even if a NO vote successfully forced a buy out, nobody has any clue. If the market cap surged to $100 million, that does not mean a healthy buy out price. It would be funny if there was a $20 million offer but could not get it approved by shareholders and company ran out of money
20 cents is very parabolic, but my guess will only happen if deep in many souls was a belief of strong imminent b/o
The realistic rally cry is one cent may hold up to reverse split, after that and if, the new guessing game will begin
On the assumption all 435 million will be voted, YES would have to be about 218 million. IF 212, 218 should be easy as that would only be 3 percent of little retail.
My theory is the 212 million did not get in the offering on quick b/o hopes
As for currently the higher the volume, the more leak out selling allowed
My 2nd theory is unit holders are willing to sell at .013 as after reverse split is their likely point of anticipation
As I said before spending was very high from 2010. After FDA submission and then later Hobbs departure, there was a period of steady reduction in work force and expenses. I have never understood why such high spending, but the fact that it has delayed ICC phase 3 and will likely go up not down from here means the description of theft is iffy
The only reason it appears that most are long is a hope of b/o very soon, that is exactly the same scenario played out after June
There is no avoiding that it is almost impossible to find posters that believe Simpson is highly motivated to accomplish good in the end as can be seen by vote sentiment. She is clearly more intelligent as well than people want to admit. I invite people to be objective, such a rarity
I can't imagine though why anybody would be pumped for the rest of this week, plenty of shares for sale from offering holders
I surely hope so. My guess is since I sold out after Sep 2013, sat out for one month, then started in again and tried swing trading to protect downside and kept usually no more than $8K into at a time:
splat cumulatively I suspect easily down $30K to $50K
That is why unless one is a super trader, timing of when to enter could be crucial to success. These deals with warrants may be a salvation for those with, but everybody in delcath world would like that the long awaited fuse was sooner rather than later
I was not surprised to hear it seems that the loosening of requirements for enrollment is not implemented. Just the real world takes time.
Phase 3 launch of ICC is now already about 6 months behind schedule, likely all due to funding needs.
A well run, truthful enough presentation imo. What is missing though, why will somebody put up as much as $20 million? I don't really need an explanation about the large sum of money, I just take it as bad news to even contemplate.
This vote will be interesting
everybody knows more money is needed to operate the 2nd phase 3, which is much needed for delcath to be a potential commercial powerhouse
Until and if there is a reverse split, it is just a case of stuffing Simpson in a tight corner as the peoples' policy
She seems to be promising info on OM phase 3 in the 2nd half of the year which means first half of year is just a financing battle and trying to put the petal to the metal on enrollment